Pure Global
NCT06346704

Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis

Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis (NHS-MS-EGYPT)
SYSNAV·ClinicalTrials.gov·otherRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Multiple Sclerosis
Drug/Device/Intervention
Digital HealthTechnology
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
SYSNAV
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Apr 25, 2024
End date
Nov 30, 2026
Enrollment
61 participants
Primary outcome

Longitudinal change of 95th centile of stride velocity

Summary

The study aims to assess the validity of real-world activity monitoring by the Syde® wearable
 device in subjects with multiple slclerosis. The Syde® collected data will be compared to
 on-site conventional clinical endpoints for MS pathology (EDSS, FSS and T25FWT). Subjects
 with multiple sclerosis will be assessed every 6 months for 2 years.

ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06346704
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06346704 through Pure Global AI's free database. This phase not specified trial is sponsored by SYSNAV and is currently Recruitment Completed. The study focuses on Multiple Sclerosis. Target enrollment is 61 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.